Paul Edward Bottinelli III
Boone Capital Management Llc
Assets Managed
$326.408M
Holdings
13
Last Quarter
2026 - Q1
Filed Date
1mo 8d ago
Growth Rate
2.45%(2Q avg: 3.47%)
Sustained Growth
3 quarters
Portfolio positions
This chart displays the top 10 holdings in Boone Capital Management Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 13 positions.
Assets under management
The assets under management (AUM) of Boone Capital Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 326.408M in assets, with a quarterly growth rate of 2.45% and a 2-quarter average growth rate of 3.47%. The portfolio is managed by Paul Edward Bottinelli III, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
MIRM Mirum Pharmaceuticals Inc
| 11.93% | $38.914M 421,236 shares@ $92.39 avg price | |
IONS Ionis Pharmaceuticals Inc
| 11.52% | $37.584M 500,522 shares@ $75.1 avg price | Increased 19.79% |
CI The Cigna Group
| 11.24% | $36.684M 137,522 shares@ $266.76 avg price | Increased 42.58% |
MDT Medtronic Plc
| 10.57% | $34.492M 398,065 shares@ $86.65 avg price | Decreased -7.16% |
TFX Teleflex Inc
| 10.22% | $33.346M 278,792 shares@ $119.61 avg price | New Position |
BMRN Biomarin Pharmaceutical Inc
| 9.49% | $30.949M 547,871 shares@ $56.5 avg price | Increased 33.02% |
GRDN Guardian Phrmcy Services-a
| 7.29% | $23.771M 631,193 shares@ $37.66 avg price | New Position |
AZNCF Astrazeneca Plc
| 6.66% | $21.714M 110,101 shares@ $197.22 avg price | New Position |
UNH Unitedhealth Group Inc
| 6.57% | $21.438M 79,226 shares@ $270.59 avg price | Increased 28.28% |
BBIO Bridgebio Pharma Inc
| 5.21% | $16.993M 228,829 shares@ $74.27 avg price | Increased 23.72% |
1-10 of 13